Inotiv, Inc. — Investor Relations & Filings

Inotiv, Inc. is a contract research organization (CRO) providing a comprehensive range of nonclinical and analytical drug discovery and development services. Key service areas include general toxicology, pathology, histology, drug metabolism and pharmacokinetics (DMPK), and bioanalytical solutions. The company also offers specialized services such as digital pathology with AI-driven image analysis, monoclonal antibody production, and developmental and reproductive toxicology (DART) studies. In addition to its CRO services, Inotiv is a major provider of research models and related products. This includes a wide array of animal models, genetically engineered model services (GEMS), contract breeding, surgical services, and Teklad laboratory animal diets and bedding. Inotiv serves clients across the pharmaceutical, biotechnology, medical device, academic, and government sectors.